Fertility and Sterility
Volume 94, Issue 5 , Pages 1782-1786 , October 2010

Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome

  • Helmy Selman, Ph.D.

      Affiliations

    • Praxi Provita, Rome, Italy
    • Corresponding Author InformationReprint requests: Helmy Selman, Ph.D., Praxi Provata Centro Fertilità, Via Magnagrecia, 117, Rome, Italy (FAX: +39-0677251000).
    • ,
  • Arianna Pacchiarotti, M.D.

      Affiliations

    • Praxi Provita, Rome, Italy
    • ,
  • Imam El-Danasouri, Ph.D.

      Affiliations

    • Istituto Europeo Medicina della Riproduzione Abruzzese (I.E.M.A.), Chieti, Italy

Received 20 June 2009 ,Revised 19 September 2009 ,Accepted 5 October 2009.

References 

  1. Lambert A, Rodgers M, Mitchell R, Wood AM, Wardle C, Hilton B, et al. In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP. Hum Reprod. 1995;10:1928–1935
  2. Lispi M, Bassett R, Crisci C, Mancinelli M, Martelli F, Ceccarelli D, et al. Comparative assessment of the consistency and quality of a highly purified FSH extracted from urine (urofollitropin) and a recombinant human FSH (follitropin α). Reprod Biomed Online. 2006;13:179–193
  3. Antonio MD, Borrelli F, Datola A, Bucci R, Mascia M, Polletta P, et al. Biological characterization of recombinant human follicle stimulating hormone isoforms. Hum Reprod. 1999;14:1160–1167
  4. Vitt UA, Kloosterboer HJ, Rose UM, Mulders JW, Kiesel PS, Bete S, et al. Isoforms of human recombinant follicle-stimulating hormone: comparison of effects on murine follicle development in vitro. Biol Reprod. 1998;59:854–861
  5. West CR, Carlson NE, Lee JS, McNeilly AS, Sharma TP, Ye W, et al. Acidic mix of FSH isoforms are better facilitators of ovarian follicular maturation and E2 production than the less acidic. Endocrinology. 2002;143:107–116
  6. Daya S. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil Steril. 2002;77:711–714
  7. Al-Inany H, Aboulghar M, Mansour R, Gamal Serour G. Meta-analysis of recombinant versus urinary-derived FSH: an update. Hum Reprod. 2003;18:305–313
  8. Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, et al. Recombinant human follicle stimulating hormone (r-FSH, Gonal-F) vs. highly purified urinary FSH (Metrodin highly purified): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod. 1997;12:2133–2139
  9. Ng EHY, Lau EYL, Yeung WSBY, Ho PC. HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial. Hum Reprod. 2001;2:319–325
  10. Strehler E, Abt M, El-Danasouri I, De Santo M, Sterzik K. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotrophins on in vitro fertilization outcome. Fertil Steril. 2001;75:332–336
  11. Selman HA, De Santo M, Sterzik K, Coccia E, El Danasouri I. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality. Fertil Steril. 2002;78:1061–1067
  12. Sairam MR, Bhargavi GN. A role for glycosylation of the alpha subunit in transduction of biological signal in glycoprotein hormones. Science. 1985;229:65–67
  13. Bishop LA, Robertson DM, Cahir N, Schofield PR. Specific roles for the asparagine-linked carbohydrate residues of recombinant human follicle-stimulating hormone in receptor binding and signal transduction. Mol Endocrinol. 1994;8:722–731
  14. Davis D, Liu X, Segaloff DL. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in receptor function. Mol Endocrinol. 1995;9:159–170
  15. Nayudu LP, Vitt UA. Barrios de Tomasi J, Pancharatna K, Ulloa-Aguirre A. Intact follicle culture: what it can tell us about the role of FSH glycoforms during follicle development. Reprod Biomed Online. 2002;5:240–253
  16. Padmanabhan V, Sairam MR, Hassing JM, Brown MB, Ridings JW, Beitins IZ. Follicle stimulating hormone signal transduction: role of carbohydrate in aromatase induction in immature Sertoli cells. Mol Cell Endocrinol. 1991;79:119–128
  17. Wide L. Follicle-stimulating hormones in anterior pituitary gland from children and adults differ in relation to sex and age. J Endocrinol. 1989;123:519–529
  18. Wide L, Bakos O. More basic forms of both human follicle stimulating hormone and luteinizing hormone in serum at mid cycle compared with the follicular and luteal phase. J Clin Endocrinol Metab. 1993;76:885–889
  19. Phillips DJ, Wide L. Serum gondotropin isoforms become more basic after an exogenous challenge of gonadotropin-releasing hormone in children undergoing pubertal development. J Clin Endocrinol Metab. 1994;79:814–819
  20. Zambrano E, Olivares A, Mendez JP, Guerrero L, Diaz-Cueto L, Veldhuis JD, et al. Dynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle. J Clin Endocrinol Metab. 1995;80:1647–1656
  21. Ulloa-Aguirre A, Damian-Matsumura P, Jimenez M, Zambarano E, Diaz-Sànchez V. Biological characterization of the isoforms of urinary human follicle stimulating hormone contained in a purified commercial preparation. Hum Reprod. 1992;7:1371–1378
  22. Caccia P. Comparative glycoforms distribution analysis of different FSH-based products present on the market. Conference on gonadotropins and receptors. Theobalds Park, Hertfordshire, United Kingdom. July 6–9, 2008,;A3:11
  23. Veeck LL. An atlas of human gametes and conception. London: Parthenon; 1999;
  24. Veeck LL. Oocyte assessment and biological performance. Ann NY Acad Sci. 1988;541:259
  25. Sundström P, Nilsson BO. Meiotic and cytoplasmic maturation of oocytes collected in stimulated cycles is asynchronous. Hum Reprod. 1988;3:613–619
  26. Moor RM, Osborn JC, Crosby IM. Gonadotrophin-induced abnormalities in sheep oocytes after superovulation. J Reprod Fertil. 1985;74:167–172
  27. Zelsinki-Wooten MB, Hess DL, Wolf D, Stouffer R. Steroid production during ovarian stimulation impairs oocyte fertilization but not folliculogenesis in rhesus monkey. Fertil Steril. 1994;61:1147–1154
  28. Wu TJ, Wang L, Wan YY. Detection of estrogen receptor messenger ribonucleic acid in human oocyte and cumulus oocyte complexes using reverse transcriptase polymerase chain reaction. Fertil Steril. 1993;59:54–59
  29. Hild-Petito S, Stouffer RL, Brenner RM. Immunocytochemical localization of estrogen and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology. 1988;123:2896–2905
  30. Tesarik J, Mendoza C. Nongenomic effects of 17β-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin. Endocrino Metab. 1995;80:1438–1443
  31. Tesarik J, Mendoza C. Direct non-genomic effects of follicular steroids on maturing human oocytes: oestrogen versus androgen antagonism. Hum Reprod Update. 1997;3:95–100
  32. Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod. 2000;15:1003–1008
  33. Fleming R, Lloyd F, Herbert M, Fenwick J, Griffiths T, Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod. 1998;13:1788–1792
  34. Fleming R, Rehka P, Deshpande N, Jamieson ME, Yates RWS, Lyall HL. Suppression of LH during ovarian stimulation effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Hum Reprod. 2000;15:1440–1445
  35. Esposito MA, Barnhart KT, Coutifaris C, Patrizio P. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle stimulating hormone. Fertil Steril. 2001;75:519–523
  36. Chappel SC, Ulloa-Aguirre A, Ramaley J. Sexual maturation in female rats: time-related changes in the isoelectric focusing pattern of anterior pituitary follicle-stimulating hormone. Biol Reprod. 1983;28:196–205
  37. Blum WF, Gupta D. Heterogeneity of rat FSH by chromatofocusing: studies on serum FSH, hormone released in vitro and metabolic clearance rates of its various forms. J Endocrinol. 1985;105:29–37
  38. Wide L. The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone. Endocrinology. 1986;112:336–344
  39. Wide L, Hobson BM. Influence of the assay method used on the selection of the most active forms of FSH from the human pituitary. Acta Endocrinol. 1986;113:17–22
  40. Ulloa-Aguirre A, Cravioto A, Damian-Matsumura P, Jimenez M, Zambrano E, Diaz-Sanchez V. Biological characterization of the naturally occurring analogues of intrapituitary human follicle-stimulating hormone. Hum. Reprod. 1992;7:23–30
  41. Flack MR, Bennet AP, Froehlich J, Anasti JN. Increased biological activity due to basic isoforms in recombinant human follicle stimulating hormone produced in a human cell line. J Clin Endocrinol Metab. 1994;79:756–760
  42. Galway AB, Hsueh AJ, Keene JL, Yamoto M, Fauser BC, Boime I. In vitro and in vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines. Endocrinology. 1990;127:93–100
  43. Vitt UA, Nayudu PL, Rose UM, Kloosterboer HJ. Embryonic development after follicle culture is influenced by follicle stimulating hormone isoelectric point charge. Biol Reprod. 2001;65:1542–1547
  44. Vitt UA, Kloosterboer HJ, Rose UM, Mulders JWM, Kiesel PS, Bete S, et al. Isoforms of human recombinant follicle-stimulating hormone: comparison of effects on murine follicle development in vitro. Biol Reprod. 1998;59:854–861
  45. Nayudu PL, Osborne SM. Factors influencing the rate of preantral and antral growth of mouse ovarian follicles in vitro. J Reprod Fertil. 1992;95:349–362
  46. Zambrano E, Barrios-de-Tomasi J, Cárdenas M, Ulloa-Aguirre A. Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone. Mol Hum Reprod. 1996;2:563–571
  47. Pacchiarotti A, Aragona C, Gaglione R, Selman H. Efficacy of a combined of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle. J Assist Reprod Genet. 2007;24:400–405
  48. Selman H. Effect of two differently glycosylated FSHs on oocyte quality and clinical outcome. Gynecol Endocrinol. 2008;24(Suppl 1):72

 H.S. has nothing to disclose. A.P. has nothing to disclose. I.E. has nothing to disclose.

PII: S0015-0282(09)03861-8

doi: 10.1016/j.fertnstert.2009.10.005

Fertility and Sterility
Volume 94, Issue 5 , Pages 1782-1786 , October 2010

Article Tools

* Image Usage & Resolution